Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster ... to ...

CROs Advance Pharmaceutical Innovation with Thermo Fisher Scientific In today’s fast-paced pharmaceutical landscape, Contract ...

The Legislature and Gov. Maura Healey last year enacted a pair of new health policy laws, including one aimed at reining in ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

New research reveals the potential of drugs that have been on the market for decades to treat diseases other than those for ...

Qualification program creates a pathway to evaluate Clinical Outcome Assessments (COAs) that capture a specific concept of interest (COI) in a specified Context of Use (COU). If successfully qualified ...

Artificial intelligence decreases a large amount of time and cost utilized in the drug discovery and development process, which is mainly influencing ... and computational biology approaches in drug ...

In this Teach Me in 10 episode, we explore how versatile data platforms can help scientists make data-driven decisions and ...

As the largest funder of biomedical research in the world, the NIH is considered a global paragon. Budget cuts could lead to ...

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

While significant progress has been made in developing treatments for rare diseases—highlighted by the approval of over 800 drugs for orphan diseases since ...

In this interview, rare disease expert Oxana Iliach discusses challenges with rare disease drug development and how they can ...